Semaglutide vs liraglutide treatment demonstrated superior weight loss at 1 year and 10% weight loss achievement among patients with obesity.

The CDC is warning the public about the potential for receiving counterfeit medications through unverified online pharmacies.

Electronic health record (EHR) documentation seen in primary care does not accurately reflect menopause symptom burden.

Catheter ablation is associated with significant reductions in AF symptoms, AF-related hospitalization, and HF symptoms across HF subtypes.

A scientific statement has been published by the American Heart Association regarding interfacility transport in patients with cardiac arrest.

Study results published in Pediatric Rheumatology suggest that maintaining sufficient serum 25 (OH)-vitamin D levels could positively influence Kawasaki disease outcomes.

The use of SGLT2 inhibitors vs DDP-4 inhibitors is associated with a reduced risk of developing different types of dementia.

Black patients are more likely to experience prolonged onset to arrival intervals and decreased odds of EMS prenotification in stroke.

The FDA has granted Orphan Drug designation to LQT-1213, a serum glucocorticoid regulated kinase 1 inhibitor, for long QT syndrome.

The guidance on existing tools for obesity management can help clinicians treat patients with or at risk for chronic kidney disease (CKD).

Tirzepatide for diabetes vs long-acting insulins demonstrated superior glycemic control and weight loss compared among adults with type 2 diabetes.

Current INSTI vs protease inhibitor or NNRTI use is linked to an increased risk for diabetes, which is slightly attenuated when adjusted for changes in BMI.